A detailed history of Clearline Capital LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Clearline Capital LP holds 336,849 shares of TEVA stock, worth $5.76 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
336,849
Previous 336,849 -0.0%
Holding current value
$5.76 Million
Previous $4.75 Million 15.17%
% of portfolio
0.16%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $7.24 Million - $9.79 Million
-678,717 Reduced 66.83%
336,849 $4.75 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $2.34 Million - $3.07 Million
288,770 Added 39.73%
1,015,566 $10.6 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $2.5 Million - $3.58 Million
-334,485 Reduced 31.52%
726,796 $7.41 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $7.64 Million - $10.1 Million
1,061,281 New
1,061,281 $7.99 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.